Related Experiment Videos

N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor

B K Trivedi¹, A J Bridges, W C Patt

¹Department of Chemistry, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.

Journal of Medicinal Chemistry

|January 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor delta agonists.

Bioorganic & medicinal chemistry letters·2007

Association of anemia with outcomes in men with moderate and severe chronic kidney disease.

Kidney international·2006

Therapeutic challenges of kinase and phosphatase inhibition and use in anti-diabetic strategy.

Biochemical Society transactions·2005

Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor.

Journal of medicinal chemistry·2001

Medicinal chemistry in the development of societies. Biodiversity and natural products.

European journal of medicinal chemistry·2001

Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in ApcMin mice but induces duodenal injury.

Cancer research·2000

See all related articles